Nexity SA (LON:0KB3)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	537	599	808	1,283	1,921	1,744
Market Cap Growth	16.67%	-25.91%	-36.97%	-33.23%	10.12%	-16.88%
Enterprise Value	1,983	2,018	2,661	2,835	3,099	3,859
Last Close Price	9.72	10.64	14.65	20.81	28.31	25.06
PE Ratio	-	-	48.51	7.70	7.04	17.23
PS Ratio	0.21	0.22	0.24	0.33	0.51	0.43
PB Ratio	0.34	0.39	0.48	0.71	1.17	1.12
P/TBV Ratio	1.21	1.30	1.56	3.37	5.04	14.91
P/FCF Ratio	3.23	3.93	5.20	7.23	53.37	2.83
P/OCF Ratio	2.60	3.13	3.90	5.37	23.46	2.55
EV/Sales Ratio	0.74	0.73	0.77	0.74	0.83	0.96
EV/EBITDA Ratio	17.93	-	13.21	8.54	9.08	14.67
EV/EBIT Ratio	-	-	17.18	9.54	9.88	17.73
EV/FCF Ratio	11.91	13.24	17.12	15.98	86.10	6.26
Debt / Equity Ratio	1.10	1.19	1.34	1.31	1.24	1.44
Debt / EBITDA Ratio	16.45	35.06	6.69	5.25	4.56	5.09
Debt / FCF Ratio	10.36	12.06	14.47	13.35	56.47	3.62
Asset Turnover	0.48	0.45	0.45	0.50	0.51	0.51
Inventory Turnover	1.35	1.43	1.34	1.52	1.69	1.86
Quick Ratio	0.69	0.71	0.53	0.58	0.60	0.51
Current Ratio	1.35	1.26	1.20	1.17	1.19	1.15
Return on Equity (ROE)	-7.53%	-3.21%	1.85%	10.25%	18.27%	6.83%
Return on Assets (ROA)	-0.74%	-1.17%	1.26%	2.40%	2.67%	1.73%
Return on Capital (ROIC)	-1.16%	-2.03%	2.42%	4.62%	5.43%	3.33%
Return on Capital Employed (ROCE)	-	-	5.40%	9.60%	11.30%	7.80%
Earnings Yield	-24.20%	-8.59%	2.06%	12.98%	14.21%	5.80%
FCF Yield	30.98%	25.45%	19.23%	13.84%	1.87%	35.36%
Dividend Yield	-	-	-	10.66%	7.42%	7.15%
Payout Ratio	-	-	724.99%	73.55%	34.05%	97.18%
Buyback Yield / Dilution	17.88%	13.95%	-1.26%	-2.51%	2.94%	-0.25%
Total Shareholder Return	-	13.95%	-1.26%	8.15%	10.35%	6.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.